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ABSTRACT
Breast lump is a very common complaint among women, especially during 
the reproductive year. Fine needle aspiration biopsy (FNAB) is a less invasive 
procedure. It is usually performed as an initial diagnosis prior to the operative 
procedure. The accuracy of the FNAB in Indonesia needs to be elaborated. 
The study aimed to evaluate the sensitivity and specificity of FNAB in 
diagnosing breast neoplasm. This is a retrospective study with cross sectional 
design, involving 145 patients with breast lump who underwent FNAB and 
histopathology examination in Dr. Sardjito General Hospital, Yogyakarta, 
from 2012 to 2014. Data analysis showed that female to male ratio was 23. 2:1 
commonly occurred at 41-50 years old. Forty-one cases (28.28%) diagnosed as 
a benign lesion with fibrocystic changes as the most frequentcase (11.19%). 
The malignant case was 104 cases (71.72%) with ductal carcinoma as the 
highest case (51.49%). FNAB achieved a sensitivity of 85.58%, a specificity of 
100% and a total accuracy of 89.66% in determining the benign or malignant 
breast lump. The accuracy, sensitivity and specificity of FNAB in diagnosing 
ductal carcinoma were 83.58%, 85.51% and 81.54%, respectively. The accuracy, 
sensitivity and specificity of FNAB to diagnose fibrocystic changes lesion were 
85.82%, 26.67% and 93.28%, respectively. FNAB can be used as an alternative 
diagnostic tool to diagnose breast neoplasm. It provides rapid, cheaper, 
effective, valuable, and less invasive procedure in diagnosis of breast lump.
ABSTRAK
Benjolan payudara adalah keluhan yang sangat umum pada wanita, khususnya 
selama usia reproduktif. Biopsi aspirasi jarum halus (BAJAH) merupakan 
prosedur yang kurang invasif, biasanya dilakukan sebagi diagnosis awal 
sebelum prosedur operasi. Keakuratan BAJAH di Indonesia perlu dijabarkan 
lagi lebih dalam. Penelitian ini bertujuan untuk mengevaluasi sensitivitas 
dan spesifitas BAJAH dalam mendiagnosis neoplasma payudara. Studi ini 
menggunakan rancangan penelitian retrospective cross-sectional, melibatkan 
145 pasien dengan benjolan payudara yang menjalani BAJAH dan pemeriksaan 
histopatologi di RSUP Dr. Sardjito, Yogyakarta, dari tahun 2012-2014. Analisis 
data menunjukkan bahwa rasio perempuan disbanding laki-laki adalah 
23, 2:1, umumnya terjadi pada usia 41-50 tahun. Empat puluh satu kasus 
(28,28%) didiagnosis sebagai lesi jinak dengan perubahan fibrokistik sebagai 
kasus yang paling sering terjadi (11,19%). Kasus ganas sebanyak 104 kasus 
(71,72%) dengan karsinoma duktus sebagai kasus tertinggi (51, 49%). BAJAH 
mencapai sensitivitas 85,58%, spesifitas 100% dan akurasi total 89,66% dalam 
menentukan benjolan payudara jinak atau ganas. Keakuratan, sensitivitas, 
dan spesifisitas BAJAH dalam mendiagnosis lesi perubahan fibrosistik adalah 
85,82%. 26,67%, dan 93,28%. BAJAH dapat digunakan sebagai alat diagnostic 
alternative untuk mendiagnosis neoplasma payudara. Prosedur ini cepat, 
murah, efektif, berharga dan kurang invasive dalam diagnosis dari benjolan 
payudara.
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INTRODUCTION
Breast lump is a very common 
complaint among women, especially 
during the reproductive year.1 Although 
breast lumps are often caused by benign 
(non-cancerous) conditions, however 
10-20% of them are cancerous.2-4 Since 
2008, the incidence of breast cancer has 
increased more than 20% worldwide 
and its mortality has increased 14%. 
The incidence rates remain high in 
developed countries while mortality rate 
are higher in developing countries due 
to lack of early detection and access to 
treatment facilities.5 If breast cancer can 
be detected and managed earlier, the 
chance of being cured will be higher and 
the mortality will be reduced.3,6
Fine needle aspiration biopsy 
(FNAB) is one of the biopsy procedures 
known to have the easiest technique and 
fewer complications.7,8 It is a procedure 
in which fine needle used to aspirate 
cellular material from a mass then 
the cytological diagnosis is rendered.9 
Moreover, FNAB also can also save time 
and equipment.10 However, FNAB has 
some limitation regarding bad sampling 
technique, specimen inadequacy, 
aspirator skills, interpretation error, and 
overlapping features between lesions.7 
Those diagnostic pit falls may lead to 
false positive or false negative result.11 
We aimed to show the effectiveness 
and accuracy of the FNAB in the 
breast lump diagnosis, in determining 
benign or malignant lesion, by showing 




This study was a descriptive non-
experimental study with retrospective 
cross sectional design. It involved 145 
breast lump patients who underwent 
FNAB and histopathology examination in 
the Department of Anatomical Pathology, 
Dr. Sardjito General Hospital, Yogyakarta 
from January 2012 to December 2014.
Protocol
The secondary data were collected 
from the medical record of the 
patient from 1st January 2012 until 31st 
December 2014. All breast lump patients 
underwent FNAB and the cytological 
diagnosis was categorized as benign 
or malignant lesion according to WHO 
classification standard. The FNAB result 
then compared with the histopathology 
result which was considered as the gold 
standard. 
Data analysis
The sensitivity, specificity, positive 
predictive value (PPV), negative 
predictive value (NPV) and diagnostic 
accuracy in breast lump diagnosis were 
calculated. Patients with incomplete 
data were excluded. Statistical analysis 
was performed using Microsoft Excel 
and SPSS software.
RESULTS
There were 145 cases included in 
this study, 139 cases (95.86%) were 
female and 6 cases (4.14%) were male, 
with female to male ratio of 23.2:1. The 
age ranged from 18 to 74 years, with the 
peak incidence in age ranged from 41 
to 50 years old. From all case, 41 cases 
(28.28%) were benign and 104 cases 
(71.72%) were malignant, consisting of 
69 cases (51.49%) of ductal carcinoma, 
15 cases (11.19%) of fibrocystic changes, 
12 cases (8.96%) of lobular carcinoma, 10 
cases (7.46%) of fibroadenoma, 6 cases 
(4.48%) of mastitis granulomatosa, 5 cases 
(3.73%) of malignant phyllodestumor, 
3 cases (2.24%) of ductulo-lobular 
carcinoma, 3 cases (2.24%) of metaplastic 
carcinoma, 2 cases (1.49%) of benign 
phyllodestumor, 2 cases (1.49%) of non-
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hodgkin lymphoma, 1 case (0.75%) of 
atypical lobular hyperplasia, 1 case 
(0.75%) of paget’s disease, 1 case (0.75%) 
of lactating carcinoma, 1 case (0.75%) 
of gynecomastia, 1 case (0.75%) of 
fibrosarcoma, 1case (0.75%) of mucinous 
carcinoma, and 1 case (0.75%) of fibrosis 
(TABLE 1).
TABLE 1. Breast lump incidence distribution in Dr. 
Sardjito General Hospital Yogyakarta 




•	 Female 139 95.86
•	 Male 6 4.14
Age
•	 <16 years old 0 0
•	 16-20 years old 4 2.84
•	 21-30 years old 12 8.51
•	 31-40 years old 28 19.86
•	 41-50 years old 51 36.17
•	 51-60 years old 33 23.4
•	 61-70 years old 9 6.38
•	 >70 years old 4 2.84
Lesion
•	 Benign 41 28.28
•	 Malignant 104 71.72
Pathological diagnosis
•	 Ductal carcinoma 69 51.49
•	 Fibrocystic changes 15 11.19
•	 Lobular carcinoma 12 8.96
•	 Fibroadenoma 10 7.46
•	 Mastitis granulomatosa 6 4.48
•	 Malignant phyllodes tumor 5 3.73
•	 Ductulo-lobular carcinoma 3 2.24
•	 Metaplastic carcinoma 3 2.24
•	 Benign phyllodes tumor 2 1.49
•	 Non Hodgkin lymphoma 2 1.49
•	 Atypical lobular hyperplasia 1 0.75
•	 Paget’s disease 1 0.75
•	 Lactating carcinoma 1 0.75
•	 Gynecomastia 1 0.75
•	 Fibrosarkoma 1 0.75
•	 Mucinous carcinoma 1 0.75
•	 Fibrosis 1 0.75
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The result of FNAB was compared 
with histopathology result in determining 
the type of lesion and the histopathology 
diagnosis. From the cytological 
examination, 89 cases (71.72%) 
diagnosed as the malignant lesion, all 
of them (100%) confirmed as malignant 
(confirmed with the histopathology 
result). From 56 cases (38.62%) benign 
lesion diagnosed by FNAB, 41 cases 
(73.21%) proofed to be benign and 15 cases 
(26.79%) were confirmed as malignant 
by histopathology analysis. Thus, 
FNAB achieved a sensitivity of 85.58%, 
specificity of 100%, positive predictive 
value of 100%, negative predictive value 
of 73.21%, and a total accuracy of 89.66% 
(TABLE 2). Furthermore, sensitivity 
and specificity of FNAB in determine 
breast lump histopathology diagnosis 
respectively 82.5% and 70.3% (FIGURE 
1); with a total accuracy of 65.67%.
TABLE 2. Sensitivity and specificity of FNAB for 






Malignant 89 0 89
Benign 15 41 56















FIGURE 1. Sensitivity and specificity of FNAB for 
determine breast lump histopathology 
diagnosis
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Ductal carcinoma was the most 
common case found in this study. Of the 
included 71 cases cytologically diagnosed 
as ductal carcinoma, 59 cases (83.1%) 
confirmed as ductal carcinoma and 12 
cases (16.9%) confirmed as other cases 
by histopathology examination. Those 
false positive were 7 cases (58.33%) as 
lobular carcinoma, 2 cases (16.67%) as 
metaplastic carcinoma, 1 case (8.33%) 
as atypical lobular hyperplasia, 1 
case (8.33%) as mucinous carcinoma 
and 1 case (8.33%) as ductulo-lobular 
carcinoma. Hence, in diagnosing ductal 
carcinoma, FNAB reached a sensitivity 
of 85.51%, specificity of 81.54%, positive 
predictive value of 83.1%, negative 
predictive value of 84.13%, and a total 
accuracy of 83.35% (TABLE 3).







Ductal carcinoma 59 12 71
Others 10 53 63
Total 69 65 134
The second most common malignant 
case found in this study was lobular 
carcinoma. From cytology diagnosis, 6 
cases diagnosed as lobular carcinoma, 
2 cases proved as lobular carcinoma 
by histopathology examination, and 
4 remaining cases missed diagnosed. 
Those remaining cases were 1 case (25%) 
as diffuse non-Hodgkin lymphoma, 1 case 
(25%) as ductal carcinoma, 1 case (25%) 
as lactating carcinoma, and 1 case (25%) 
as ductulo-lobular carcinoma. Therefore, 
in diagnosing lobular carcinoma, FNAB 
had a sensitivity of 16.67%, specificity 
of 96.72%, positive predictive value of 
33.33%, negative predictive value of 
92.19%, and a total accuracy of 89.55% 
(TABLE 4).







Lobular carcinoma 2 4 6
Others 10 118 128
Total 12 122 134
The most common benign lesion 
found in this study was fibrocystic 
changes. Twelve cases were cytologically 
diagnosed as fibrocystic changes, 4 of 
them (33.33%) proved histologically, 
meanwhile 8 of them (66.67%) falsely 
diagnosed with 5 cases (62.5%) of 
ductal carcinoma, a case (12.5%) of 
benign phyllodestumor, a case (12.5%) 
of gynecomastia, and a case (12.5%) of 
fibroadenoma. In diagnosing fibrocystic 
lesion, FNAB showed a sensitivity of 
26.67%, specificity of 93.28%, positive 
predictive value of 33.33%, negative 
predictive value of 90.98%, and a total 
accuracy of 85.82% (TABLE 5).
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Fibrocystic changes 4 8 12
Others 11 111 122
Total 15 119 134
Fibroadenoma was the second 
most frequent benign lesion found 
in this study. Sixteen cases revealed 
as fibroadenoma through cytology 
examination. Histopathologicaly, 9 
of them (56.25%) were confirmed as 
fibroadenoma, and 7 cases (43.75%) were 
confirmed as non-fibroadenoma lesion. 
The false positive cases were confirmed 
4 cases (57.14%) as fibrocystic lesion, 
1 case (14.29%) as lobular carcinoma, 
1 case (14.29%) as ductal carcinoma 
and 1 case (14.29%) as ductulo-lobular 
carcinoma. In diagnosing fibroadenoma, 
FNAB attained a sensitivity of 90%, 
specificity of 94.35%, positive predictive 
value of 56.25%, negative predictive 
value of 99.15%, and a total accuracy of 
94.03% (TABLE 6).








Fibroadenoma 9 7 16
Others 1 117 118
Total 10 124 134
DISCUSSION
There are some diagnostic tools that 
can be used to diagnose the breast lump; 
such as breast ultrasound, mammogram, 
magnetic resonance imaging (MRI), 
histopathology examination and 
biopsy.12 Biopsy is considered as the only 
diagnostic procedure that can definitely 
determine whether the suspicious area 
is either benign or malignant lesion.13 
FNAB was the first percutaneous 
needle sampling technique introduced 
as in alternative for surgical biopsy.14 
This procedure is generally accurate 
and can prevent patient from having 
surgical biopsy that is more painful and 
expensive.15
As reported in other literature, age 
and gender were associated factors of 
the breast lump.3 In the present study, 
there was a female predominance with 
female to male ratio of 23.2:1 and mostly 
occurred in the age range from 41-50 
years old. These factors were related to 
hormone exposure, other factors than 
age and gender such as reproductive 
history, breastfeeding, alcohol, body 
weight, physical activity, exogenous 
hormone, endogenous hormone, 
radiation exposure, and exposure to the 
chemical with estrogen-like effects.3,5
Unlike other literature that states the 
benign cases presented as the majority of 
cases, this study showed that most of the 
cases were malignant lesion.1-3 This study 
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was conducted in referral hospital; these 
might become the main reason why we 
found more malignant cases. Ductal 
carcinoma became the most frequent 
malignant lesion (51.49%), followed by 
lobular carcinoma with the incidence of 
8.96%. Meanwhile, the first and second 
most common cases for benign lesion 
were respectively fibrocystic change 
(11.19%) and fibroadenoma (7.46%). 
In our series, analysis of data revealed 
sensitivity of 85.58%, specificity of 
100%, positive predictive value of 100%, 
negative predictive value of 73.21%, 
and a total accuracy of 89.66%. Our 
results were comparable with published 
data where FNAB was reported to 
have sensitivity of 98%, specificity of 
100%, positive predictive value of 97%, 
negative predictive value of 100% and a 
total accuracy of 98%.16 There is a wide 
range difference in the determinant 
factor. It might be due to the different 
number of cases and interpretation 
error. The diagnostic test is useful to 
detect a person with the disease or 
exclude a person without the disease. 
In this case, the result of the test is high 
in sensitivity, means will help to rule 
out malignancy if the result rendered 
benign. Moreover, the result of the test is 
high in specificity also, means it will help 
to rule in the malignancy if the result 
rendered malignant.17
Previous report revealed FNAB 
sensitivity of 93.6%, specificity of 
95%,positive predictive value of 99%, 
negative predictive value of 73% and a 
total accuracy of 94%.18 Theoretically, 
ideal diagnostic test has both 100% 
sensitivity and specificity; however 
those were not realized in real settings.19 
Sensitivity and specificity are inversely 
proportional, means when the sensitivity 
increase then the specificity will decrease 
and vice versa.20 The false negative 
rate (FNR) is defined as percentage of 
patients with benign cytology which 
turned out to be malignant after 
confirmed histopathologicaly.21,22 This 
is an important point to be concerned 
since it indicates the potential of miss 
malignant feature. The false negative 
FNAB results may occur due to both 
diagnostic errors and true false negative 
factors.23 Diagnostic errors include 
the skills and experience of aspirator, 
overload of cases, miscorrelation with 
the patient’s clinical and radiologic 
findings, and interpretation error. True 
false negative factors consist of sampling 
error, missed localization of tumor and 
cytomorphologic overlapping.11,23
The false positive rate (FPR) 
indicates that a patient with malignant 
FNAB result was found on histological 
examination to have benign lesion.21,22 
False positive diagnosis in aspiration 
cytology is significantly lower in 
incidence compared to false negative 
cases.24 False positive happened usually 
because of an interpretation error.11 
In our study, the FPR was 0% which 
similar to other studies.24 In determining 
specific diagnosis, FNAB was highly 
sensitive in diagnosing ductal carcinoma 
and fibroadenoma (85.51% and 90%). 
However, we could still find some 
false positive and false negative result. 
False positive mostly appeared due to 
interpretation error such as it was tough 
to have lesion interpretation. Meanwhile, 
false negative usually occurred due 
to sampling and interpretation error, 
especially when involving types of 
pathology that known to be difficult such 
as lobular carcinomaand fibrocystic 
changes.11
CONCLUSION
In conclusion, the result of the study 
is comparable with the published data 
and it shows that FNAB is highly sensitive 
and specific diagnostic tools, thus FNAB 
can be used as an alternative diagnostic 
tool. FNAB has high accuracy in 
determining benign or malignant breast 
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lump as it provides rapid, economical 
(cheaper), effective, valuable and less 
invasive diagnostic tools.
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